These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 16951733)

  • 21. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
    Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurotoxicity of amphetamines during the adolescent period.
    Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
    Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 'real bad' drug.
    Smith SD
    Minn Med; 2005 Aug; 88(8):6-7. PubMed ID: 16225323
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
    Lu T; Kim PP; Greig NH; Luo Y
    Neurotox Res; 2017 Aug; 32(2):218-230. PubMed ID: 28342134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
    Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxicity of methamphetamine: Main effects and mechanisms.
    Jayanthi S; Daiwile AP; Cadet JL
    Exp Neurol; 2021 Oct; 344():113795. PubMed ID: 34186102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
    Lyvers M
    Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 30. Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?
    Caligiuri MP; Buitenhuys C
    Neuropsychopharmacology; 2005 Dec; 30(12):2125-34. PubMed ID: 16123755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurologic manifestations of chronic methamphetamine abuse.
    Rusyniak DE
    Psychiatr Clin North Am; 2013 Jun; 36(2):261-75. PubMed ID: 23688691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies.
    McDonnell-Dowling K; Kelly JP
    Curr Neuropharmacol; 2017; 15(2):300-314. PubMed ID: 27121285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of the new scene drug "crystal meth" on oral health: a case-control study.
    Rommel N; Rohleder NH; Wagenpfeil S; Härtel-Petri R; Jacob F; Wolff KD; Kesting MR
    Clin Oral Investig; 2016 Apr; 20(3):469-75. PubMed ID: 26174081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood.
    Williams MT; Blankenmeyer TL; Schaefer TL; Brown CA; Gudelsky GA; Vorhees CV
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):163-75. PubMed ID: 14741761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
    Furlong TM; Leavitt LS; Keefe KA; Son JH
    Neurotox Res; 2016 May; 29(4):569-82. PubMed ID: 26846719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of methamphetamine exposure in adolescent mice on the future ovarian reserve in adulthood.
    Wang L; Qu G; Dong X; Huang K; Kumar M; Ji L; Wang Y; Yao J; Yang S; Wu R; Zhang H
    Toxicol Lett; 2016 Feb; 242():1-8. PubMed ID: 26657179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice.
    Avila JA; Memos N; Aslan A; Andrejewski T; Luine VN; Serrano PA
    J Psychopharmacol; 2021 Oct; 35(10):1240-1252. PubMed ID: 34587831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.
    Cadet JL; Krasnova IN
    Neurotox Res; 2007 Oct; 12(3):181-204. PubMed ID: 17967742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.